Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 35Other hematologic neoplasm 25Sarcoma 9Myeloid 8CNS 6Breast 3Other solid neoplasm 2Other neoplasm 2Genitourinary 2Thoracic 1Plasma cell 1Gynecologic 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Testicular Neoplasms 2Teratoma 1Seminoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1

Interventions

Docetaxel 191Gemcitabine 148Prednisone 142pembrolizumab 125enzalutamide 119Abiraterone Acetate 108Nivolumab 107Cisplatin 103Magnetic Resonance Spectroscopy 100Radiotherapy 95Sunitinib 94Leuprolide 91Carboplatin 82Specimen Handling 71Androgen Antagonists 63bicalutamide 60Radiosurgery 60Paclitaxel 59Goserelin 59Ipilimumab 57Bevacizumab 57apalutamide 53Sorafenib 53acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 51Everolimus 49cabozantinib 48abiraterone 46atezolizumab 45cabazitaxel 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Mesna × Genitourinary × Clear all
NCT00936936 2024-08-26

High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

M.D. Anderson Cancer Center

Phase 2 Completed
64 enrolled 10 charts
Genitourinary

Testicular Neoplasms

NCT00432094 2022-05-17

Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
23 enrolled 11 charts
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡